The contract biotech company plans to invest around $50 million to buy and renovate a Baltimore facility as it shifts more ...
Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.
21h
Zacks.com on MSNMerck (MRK) Advances While Market Declines: Some Information for InvestorsIn the closing of the recent trading day, Merck (MRK) stood at $94.71, denoting a +1.46% change from the preceding trading day.
The combination demonstrated non-inferiority to comparator antiretroviral therapies, meeting the primary efficacy success ...
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...
The Prayoga Institute of Education Research, in partnership with Merck, extends its Kriya initiative to 45 government schools across Karnataka, enhancing science education for over 7,000 students.
This week's dividend activity included increased payouts from Advanced Materials (AMAT) and Dick's Sporting Goods (DKS) as ...
K reports of America’s largest pharmaceutical companies show that they continue to avoid paying much, if any, U.S. corporate income tax.
The 5th Medical Device Software Development Summit is your must-attend opportunity to gain actionable strategies, real-world ...
Clair Merckx has channeled a lot into her young hockey career so far. As one chapter concludes she’s hoping the next will ...
6h
Barchart on MSNGilead Sciences - Leader in HIV MedicinesYour FREE insider update on the biggest news stories and investing trends, delivered midday TheChart of the Day belongs to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results